BAMCO Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169M Buy
140,540
+55,474
+65% +$56.7M 0.25% 43
2026
Q1
$78.2M Sell
85,066
-1,410
-2% -$1.43M 0.24% 71
2025
Q4
$92.9M Buy
86,476
+863
+1% +$825K 0.25% 74
2025
Q3
$65.3M Sell
85,613
-13,026
-13% -$9.69M 0.17% 110
2025
Q2
$76.9M Buy
98,639
+65,795
+200% +$51.1M 0.21% 97
2025
Q1
$27.1M Buy
32,844
+12,844
+64% +$10.7M 0.08% 177
2024
Q4
$15.4M Sell
20,000
-3,000
-13% -$2.48M 0.04% 217
2024
Q3
$20.4M Sell
23,000
-1,000
-4% -$899K 0.05% 199
2024
Q2
$21.7M Sell
24,000
-2,000
-8% -$1.6M 0.06% 196
2024
Q1
$20.2M Sell
26,000
-8,592
-25% -$6.11M 0.05% 209
2023
Q4
$20.2M Hold
34,592
0.05% 200
2023
Q3
$18.6M Hold
34,592
0.05% 200
2023
Q2
$16.2M Hold
34,592
0.04% 220
2023
Q1
$11.9M Hold
34,592
0.04% 228
2022
Q4
$12.7M Buy
34,592
+1,700
+5% +$603K 0.04% 209
2022
Q3
$10.6M Buy
32,892
+900
+3% +$285K 0.03% 233
2022
Q2
$10.4M Buy
+31,992
New +$9.6M 0.03% 247

Other funds holding LLY

BAMCO Inc's LLY Position: Q2 2026 in Review

BAMCO Inc increased its Eli Lilly (LLY) stake by 65% in Q2 2026, buying an estimated $56.7M and bringing the position to 140,540 shares worth $169M. The position accounts for 0.25% of the portfolio, ranked #43.

BAMCO Inc first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BAMCO Inc held 140,540 shares of Eli Lilly worth $169M as of Q2 2026.
  • BAMCO Inc bought 55,474 Eli Lilly shares in Q2 2026, an estimated $56.7M.
  • Eli Lilly made up 0.25% of BAMCO Inc's portfolio in Q2 2026, its #43 holding.
  • BAMCO Inc first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.